ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

19.90
Delayed Data
As of Apr 20
 +0.24 / +1.22%
Today’s Change
15.74
Today|||52-Week Range
41.20
-33.91%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baity Glenn F
General Counsel & Executive Vice President
Sale1/02/201874,321$30.14$2.2M-34.60%
Baity Glenn F
General Counsel & Executive Vice President
Sale1/29/201836,558$32.39$1.2M-37.30%
Baity Glenn F
General Counsel & Executive Vice President
Sale7/20/201738,097$30.00$1.1M-33.87%
Baity Glenn F
General Counsel & Executive Vice President
Sale8/30/201726,507$34.87$924.3K-42.68%
Brege Laura A
Director
Sale1/02/201825,000$30.06$751.5K-34.60%
Baity Glenn F
General Counsel & Executive Vice President
Sale8/09/201714,322$34.88$499.6K-40.08%
Baity Glenn F
General Counsel & Executive Vice President
Buy1/02/201874,321$2.18$162.0K-34.60%
Brege Laura A
Director
Buy1/02/201815,000$8.06$120.9K-34.60%
Baity Glenn F
General Counsel & Executive Vice President
Buy1/10/201850,179$2.18$109.4K-30.49%
Brege Laura A
Director
Buy1/02/201810,000$8.49$84.9K-34.60%
Page of 3